8 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
Follow Visceral Leishmaniasis: new trials by email Literature Review of Visceral Leishmaniasis trials Research Report on Visceral Leishmaniasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa Miltefosine, Paromomycin, Sodium stibogluconate - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 439 | 2018-01-24 | 2024-02-29 |
| Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. Liposomal Amphotericin B, Miltefosine - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 59 | 2014-07-01 | 2019-04-08 |
| Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh Liposomal amphotericin B, liposomal amphotericin B + miltefosine, liposomal amphotericin B + paromomycin - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 602 | 2010-05-01 | 2016-01-21 |
| Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis Amphotericin B Deoxycholate, Ambisome + Miltefosine, Ambisome and Paromomycin - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 634 | 2008-06-01 | 2010-02-11 |
| An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis Paromomycin - Visceral Leishmaniasis | Phase 3 | Completed | Banaras Hindu University | 329 | 2008-02-01 | 2008-09-12 |
| Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis Liposomal Amphotericin B, amphotericin B deoxycholate - Visceral Leishmaniasis | Phase 3 | Completed | Banaras Hindu University | 400 | 2008-02-01 | 2009-04-03 |
| Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis Sodium Stibogluconate, Paromomycin sulphate, SSG and Paromomycin sulphate - Visceral Leishmaniasis | Phase 3 | Completed | Drugs for Neglected Diseases | 1142 | 2004-11-01 | 2016-03-22 |
| Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis Paromomycin sulfate, Amphotericin B - Visceral Leishmaniasis | Phase 3 | Completed | PATH | 667 | 2003-06-01 | 2014-10-03 |
Euglenozoa Infections (8) · Infections (8) · Leishmaniasis (8) · Parasitic Diseases (8) · Protozoan Infections (8) · Vector Borne Diseases (8)
Paromomycin (6) · liposomal amphotericin B (4) · miltefosine (4) · Antimony Sodium Gluconate (2) · amphotericin B, deoxycholate drug combination (2) · Amphotericin B (1)
Drugs for Neglected Diseases (5) · Banaras Hindu University (2) · PATH (1)
India (4) · Ethiopia (3) · Kenya (2) · Sudan (2) · Uganda (2) · Bangladesh (1)
Shyam Sundar, MD (2) · Ahmed M Musa, MD, Prof (1) · Dr. S.K. Bhattacharya (1) · Ermias Diro, Dr. MD (1) · Farrokh Modabber (1) · Jane Mbui, MD (1) · Joseph Olobo, MD, Prof (1) · Manica Balasegaram (1) · Prof C.P. Thakur (1) · Prof S. Sundar (1) · Prof T.K. Jha (1) · Rezika Mohammed, MD (1) · Ridwanur Rahman, MD (1)
PMID 17582067, PMID 19663597, PMID 20147716, PMID 21049063, PMID 21255828, PMID 22724029, PMID 28558062, PMID 30653490, PMID 30789910, PMID 36164254